Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalitie...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Dec 31, 2025
Q1 2025
Mar 31, 2025
FY 2024
Dec 31, 2024